| Name | GSK717 | 
|---|---|
| Synonyms | MFCD32671947 | 
| Description | GSK717 is a potent, selective NOD2 (nucleotide-binding oligomerization domain 2) inhibitor. GSK717 inhibits muramyl dipeptide (MDP)-induced NOD2-mediated signaling, with an IC50 of 400 nM for MDP-stimulated IL-8 secretion in HEK293/hNOD2 cells[1]. | 
|---|---|
| Related Catalog | |
| In Vitro | GSK717 blocks synergy between NOD2 and TLR2. GSK717 does not affect NOD1, TNFR1 and TLR2-mediated responses. GSK717 (5 μM) inhibits the release of IL-8, IL-6, TNFα and IL-1β in primary human monocytes stimulated with MDP[1]. | 
| References | 
| Molecular Formula | C28H28N4O2 | 
|---|---|
| Molecular Weight | 452.55 | 
| Hazard Codes | Xi | 
|---|